Table 2.

Long-term post-bevacizumab radiographic response

Patient	Days after discontinuation	Volume change from pre-bevacizumab (%)		Volume change from pre-discontinuation (%)
		FLAIR	Post-contrast	FLAIR	Post-contrast
3a	75	−60.5	−38.4	−38.6	64.6
3b		−89.5	−2.5	−89.5	209.5
3c		−93.3	20.9	1.6	144.3
6	103	17.2	247.7	196.4	514.5
7	101	49.1	316.2	236.1	1014.3
9	121	−89.2	−70.5	26.2	86
11	106	−99.2	−76.2	20.8	−7.3
Mean	101.2	−52.2	56.7	50.4	289.4

Abbreviations: FLAIR, fluid-attenuated inversion recovery MRI.